Treatment overview of axial spondyloarthritis in 2023

Dr. Baraliakos: Research Support: Abbvie, Novartis, and MSD; Consultant, Speakers Bureau, Scientific Advisory Board and Honoraria: Abbvie, Amgen, BMS, Chugai, Galapagos, Gilead, Lilly, MSD, Novartis, Pfizer, Roche, Sandoz, and UCB.

Dr. Kiltz has received a grant, research support, and consultancy fees from AbbVie, Amgen, Biocad, Biogen, BMS, Chugai, Eli Lilly, Fresenius, Gilead, Grünenthal, GSK, Hexal, Janssen, MSD, Novartis, onkowissen.de, Pfizer, Roche, UCB, and Viatris.

Dr. Ciurea received

Comments (0)

No login
gif